← Open Payments lookup

JEANINE O'HAGAN: Open Payments

NPI 1679914360 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,655 in 14 payments from 9 companies in 2025. Trend: 2023 $241 · 2024 $879 · 2025 $1,655

Food & beverage: $1,655
CompanyPaymentsAmount
Gilead Sciences, Inc.4$458
Otsuka Pharmaceutical Development & Commercialization, Inc.2$223
Amgen Inc.2$186
Otsuka America Pharmaceutical, Inc.1$150
Abbott Laboratories1$138
Xeris Pharmaceuticals, Inc.1$135
E.R. Squibb & Sons, L.L.C.1$126
ABBVIE INC.1$124
GlaxoSmithKline, LLC.1$114

Products named: Epclusa, KRYSTEXXA, REXULTI, FREESTYLE LIBRE 3, GVOKE HYPOPEN, COBENFY, Vemlidy, RINVOQ.

Industry payments across NY — which companies pay providers there.